BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38347094)

  • 1. HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study.
    Prete AA; Angerilli V; Bergamo F; Vettore V; De Toni C; Intini R; Cerma K; Ricagno G; Cerantola R; Perissinotto E; De Rosa A; Ceccon C; Gasparello J; Denaro L; D'Amico A; Chioffi F; Carcea E; Fassan M; Lonardi S
    Br J Cancer; 2024 May; 130(8):1316-1323. PubMed ID: 38347094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study.
    Chen PC; Yeh YM; Chu CT; Su PF; Chiu PH; Lin BW; Chen SH; Lin PC; Lee CT; Chen HHW; Chen CC
    Eur J Cancer; 2023 Mar; 181():62-69. PubMed ID: 36640475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
    Darlix A; Griguolo G; Thezenas S; Kantelhardt E; Thomssen C; Dieci MV; Miglietta F; Conte P; Braccini AL; Ferrero JM; Bailleux C; Jacot W; Guarneri V
    J Neurooncol; 2018 Jun; 138(2):369-382. PubMed ID: 29488184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.
    Miao E; Eichholz JE; Lebow ES; Flynn J; Zhang Z; Walch H; Hubbeling H; Beal K; Moss NS; Yu KK; Meng A; Kelly DW; Gomez DR; Li BT; Rimner A; Schultz N; Drilon A; Imber BS; Pike LRG
    Lung Cancer; 2023 Apr; 178():57-65. PubMed ID: 36780766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for brain metastases in patients with metastatic colorectal cancer.
    Christensen TD; Palshof JA; Larsen FO; Høgdall E; Poulsen TS; Pfeiffer P; Jensen BV; Yilmaz MK; Christensen IJ; Nielsen D
    Acta Oncol; 2017 May; 56(5):639-645. PubMed ID: 28447565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of HER2 status in surgically resected colorectal liver metastases.
    Han J; Wang X; Zhang C; Wu Q; Ma X; Li Y; Chen Z; Zhang R; Zhang G; Lin J; Lu L; Zhu W; Jia H; Zhang J; Fan J; Chen J
    J Surg Oncol; 2022 May; 125(6):991-1001. PubMed ID: 35150441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
    Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of human epidermal growth factor receptor 2 status and systemic therapy in breast cancer with brain metastases treated with radiotherapy.
    Tsuruoka S; Kataoka M; Uwatsu K; Makita K; Tsuruoka K; Takata N; Ishikawa H; Hamamoto Y; Mochizuki T; Kido T
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):347-354. PubMed ID: 36281655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of colorectal cancer patients with brain metastases.
    Roussille P; Auvray M; Vansteene D; Lecomte T; Rigault E; Maillet M; Locher C; Dior M; Hautefeuille V; Artru P; Mabro M; Touchefeu Y; Marthey L; Moulin V; Louafi S; Lecaille C; Chautard R; Lièvre A; Zaanan A; Bennouna J; Berger A; Emambux S; Randrian V; Tougeron D
    Radiother Oncol; 2021 May; 158():67-73. PubMed ID: 33600872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry.
    Laakmann E; Witzel I; Neunhöffer T; Park-Simon TW; Weide R; Riecke K; Polasik A; Schmidt M; Puppe J; Mundhenke C; Lübbe K; Hesse T; Thill M; Zahm DM; Denkert C; Fehm T; Nekljudova V; Rey J; Loibl S; Müller V
    ESMO Open; 2022 Jun; 7(3):100495. PubMed ID: 35653983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.
    Priedigkeit N; Hartmaier RJ; Chen Y; Vareslija D; Basudan A; Watters RJ; Thomas R; Leone JP; Lucas PC; Bhargava R; Hamilton RL; Chmielecki J; Puhalla SL; Davidson NE; Oesterreich S; Brufsky AM; Young L; Lee AV
    JAMA Oncol; 2017 May; 3(5):666-671. PubMed ID: 27926948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognostic factors of brain metastases from colorectal cancer: a single center experience.
    Gao Z; Jin X; Wu S
    Int J Colorectal Dis; 2023 Jul; 38(1):198. PubMed ID: 37466736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis.
    Nader-Marta G; Martins-Branco D; Agostinetto E; Bruzzone M; Ceppi M; Danielli L; Lambertini M; Kotecki N; Awada A; de Azambuja E
    ESMO Open; 2022 Jun; 7(3):100501. PubMed ID: 35653982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive profiling of the immune microenvironment of breast cancer brain metastases.
    Griguolo G; Tosi A; Dieci MV; Fineberg S; Rossi V; Ventura A; Bottosso M; Bauchet L; Miglietta F; Jacob J; Rigau V; Fassan M; Jacot W; Conte P; Rosato A; Darlix A; Guarneri V
    Neuro Oncol; 2022 Dec; 24(12):2146-2158. PubMed ID: 35609559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic analysis of stereotactic radiosurgery for brain metastases: a single-center retrospective study.
    Hao Y; Tang T; Ren J; Li G
    Radiol Med; 2023 Oct; 128(10):1271-1283. PubMed ID: 37648956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.
    Arrieta O; Ramírez-Tirado LA; Caballé-Perez E; Mejia-Perez A; Zatarain-Barrón ZL; Cardona AF; Lozano-Ruíz F; Segura-González M; Cruz-Rico G; Maldonado F; Rosell R
    Thorac Cancer; 2020 Apr; 11(4):1026-1037. PubMed ID: 32072746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
    Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
    Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors.
    Aprile G; Casagrande M; De Maglio G; Fontanella C; Rihawi K; Bonotto M; Pisa FE; Tuniz F; Pizzolitto S; Fasola G
    Future Oncol; 2017 Jan; 13(2):135-144. PubMed ID: 27578453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.